StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PRPH

ProPhase Labs, Inc.

PRPH OTC Pharmaceutical Preparations EDGAR ↗
$0.04
-0.01 -20.00%

Key statistics

from XBRL data in SEC filings
Market cap
$561K
Revenue (TTM)
$4.08M
Net income (TTM)
-$23.9M
EPS (TTM)
$-3.29
P/E ratio
Dividend yield
750.00%
Free cash flow
Cash
$31.0K
Total assets
$58.5M
Gross margin
28.2%
52-week range
$0.03 – $6.70

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q/A Quarter ended 2026-03-31 Jul 9, 2026 10-Q/A Quarter ended 2026-03-31 Jul 7, 2026 10-Q Quarter ended 2026-03-31 Jun 30, 2026 10-K Fiscal year ended 2025-12-31 Jun 1, 2026 8-K Other events Feb 13, 2026 8-K Other events Feb 13, 2026 8-K Other events Jan 27, 2026 8-K Other events Jan 23, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 23, 2026 8-K Other events Jan 9, 2026 8-K Director or officer change Jan 9, 2026 8-K Delisting notice or listing-rule failure Jan 2, 2026 8-K Other events Dec 19, 2025 8-K Other events Dec 19, 2025 8-K/A Amended charter or bylaws; Other events Dec 18, 2025 8-K/A Amended charter or bylaws; Other events Dec 12, 2025 8-K Amended charter or bylaws; Other events Dec 12, 2025 8-K Shareholder vote results Nov 26, 2025 8-K Other events Nov 25, 2025 8-K Entered a material agreement; Other events Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 19, 2025 8-K Entered a material agreement Oct 15, 2025 8-K Entered a material agreement Sep 18, 2025 8-K Entered a material agreement; Director or officer change; Amended charter or bylaws; Shareholder vote results Sep 15, 2025 8-K Terminated a material agreement Aug 28, 2025 8-K Regulation FD disclosure; Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2025 8-K Director or officer change Aug 6, 2025 8-K Regulation FD disclosure; Other events Jul 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jul 28, 2025 8-K Shareholder vote results; Other events Jul 25, 2025 8-K Regulation FD disclosure; Other events Jul 23, 2025 8-K Regulation FD disclosure; Other events Jul 21, 2025 8-K Delisting notice or listing-rule failure Jul 1, 2025 8-K/A Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 26, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Jun 26, 2025 8-K Director or officer change Jun 25, 2025